52
Participants
Start Date
July 1, 2020
Primary Completion Date
November 24, 2023
Study Completion Date
November 24, 2023
VB10.16
Vaccination
Atezolizumab
Intravenously infusion
Cliniques Universitaires Saint-Luc, Brussels
Hopital de Libramont, Brussels
Multiprofile Hospital for Active Treatment for Women's Health - Nadezhda Sofia, Sofia
"University Multiprofile Hospital for Active Treatment Sv. Ivan Rilski", Sofia
"Multiprofile Hospital for Active Treatment Serdika EOOD", Sofia
University Multiprofile Hospital For Active Treatment Sofiamed, Sofia
Chu Ucl Namur, Namur
Universitair Ziekenhuis Gent (Uz Gent), Ghent
University Hospital Kralovske Vinohrady, Prague
Nemocnice Pardubickeho Kraje Pardubicka Nemocnice, Pardubice
Masaryk Memorial Cancer Institute, Brno
Nemocnice Na Bulovce, Prague
Universitatsklinikum Augsburg, Augsburg
University Clinic Carl Gustav Carus, Dresden
Universitatsklinikum Hamburg-Eppendorf, Hamburg
Medizinische Hochschule Hannover, Hanover
Medizinische Fakulat Mannheim Der Universitat Heidelberg, Heidelberg
Jagielońskie Centum Innowacji, Centrum Badań Klinicznych JCI, Krakow
Wielkopolskie Centrum Onkologii, Poznan
'Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie, Warsaw
Oslo University Hospital, Oslo
Lead Sponsor
Roche Pharma AG
INDUSTRY
Vaccibody AS
INDUSTRY
Nykode Therapeutics ASA
INDUSTRY